FN2 Earnings Intelligence
The Clorox Company financials
The Clorox Company (CLX) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 est. | 6/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $319 | $183 | $367 | $202 | $167 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $6,124 | $7,107 | $7,389 | $7,093 | $7,104 | $6,684.4 | $7,586.4 |
| % Growth | 0.0% | 16.1% | 4.0% | -4.0% | 0.2% | -5.9% | 13.5% |
| Gross Profit | $3,199 | $2,545 | $2,908 | $3,048 | $3,213 | - | - |
| % Margin | 52.2% | 35.8% | 39.4% | 43.0% | 45.2% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $710 | $462 | $149 | $280 | $810 | - | - |
| % Margin | 11.6% | 6.5% | 2.0% | 3.9% | 11.4% | - | - |
| Diluted EPS | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 | $5.52 | $5.93 |
| % Growth | -24.2% | -33.2% | -67.8% | 87.5% | 189.8% | -15.3% | 7.5% |
| Operating Cash Flow | $1,276 | $786 | $1,158 | $695 | $981 | - | - |
| CapEx | $331 | $251 | $228 | $212 | $220 | - | - |
| Free Cash Flow | $945 | $535 | $930 | $483 | $761 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 est. | 6/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $6,124 | $7,107 | $7,389 | $7,093 | $7,104 | $6,684.4 | $7,586.4 |
| Gross Profit | $3,199 | $2,545 | $2,908 | $3,048 | $3,213 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $710 | $462 | $149 | $280 | $810 | - | - |
| Diluted EPS | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 | $5.52 | $5.93 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $319 | $183 | $367 | $202 | $167 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $2,484 | $2,474 | $2,477 | $2,481 | $2,484 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1,276 | $786 | $1,158 | $695 | $981 |
| Capital Expenditure | $331 | $251 | $228 | $212 | $220 |
| Free Cash Flow | $945 | $535 | $930 | $483 | $761 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 0.0% | 16.1% | 4.0% | -4.0% | 0.2% |
| Gross Margin | 52.2% | 35.8% | 39.4% | 43.0% | 45.2% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 11.6% | 6.5% | 2.0% | 3.9% | 11.4% |
| FCF Margin | 15.4% | 7.5% | 12.6% | 6.8% | 10.7% |
| Diluted EPS Growth | -24.2% | -33.2% | -67.8% | 87.5% | 189.8% |